ISRG240628C400000
- 44.60
- 0.000.00%
Intuitive Surgical Newsroom
Evercore ISI Adjusts Price Target on Intuitive Surgical to $425 From $385, Maintains In-line Rating
BTIG Adjusts Price Target on Intuitive Surgical to $451 From $421
Intuitive Surgical Inc: Goldman Sachs starts insurance with a buy rating; target share price is $500
Intuitive Surgical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Intuitive Surgical (ISRG) and Silence Therapeutics (SLN)
Citi Upgrades Edwards, Tandem; Cuts Nevro, Establishment Labs
Buy Rating Affirmed for Intuitive Surgical Amidst Ongoing Legal Challenges and Strong Financial Performance
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
Intuitive Surgical (ISRG) Gets a Buy From Barclays
Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Accolade (ACCD) and Intuitive Surgical (ISRG)
BTIG: Maintains the Intuitive Surgical (ISRG.US) rating, adjusted from buy to buy rating, and adjusted the target price from $412.00 to $421.00.
Intuitive Surgical Analyst Ratings
Jefferies Investment Bank: Maintaining the Intuitive Surgical (ISRG.US) rating, adjusted from holding to holding rating, and adjusted the target price from $365.00 to $375.00.
Intuitive Surgical (ISRG) Receives a Hold From Oppenheimer
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Revolution Medicines (RVMD)
Piper Sandler Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Sarepta Therapeutics (SRPT) and Intuitive Surgical (ISRG)
Intuitive Surgical Analyst Ratings
Baird Maintains Outperform on Intuitive Surgical, Lowers Price Target to $436
Buy Rating Affirmed for Intuitive Surgical Amid Strong Q1 Performance and Positive Outlook